U.S. Markets open in 1 hr 3 mins
  • S&P Futures

    4,161.50
    -3.25 (-0.08%)
     
  • Dow Futures

    34,006.00
    -10.00 (-0.03%)
     
  • Nasdaq Futures

    13,897.25
    -22.00 (-0.16%)
     
  • Russell 2000 Futures

    2,229.30
    -9.10 (-0.41%)
     
  • Crude Oil

    61.44
    +0.09 (+0.15%)
     
  • Gold

    1,784.10
    -9.00 (-0.50%)
     
  • Silver

    26.35
    -0.22 (-0.81%)
     
  • EUR/USD

    1.2050
    +0.0010 (+0.0843%)
     
  • 10-Yr Bond

    1.5640
    0.0000 (0.00%)
     
  • Vix

    17.28
    -1.40 (-7.49%)
     
  • GBP/USD

    1.3869
    -0.0063 (-0.4535%)
     
  • USD/JPY

    108.1690
    +0.1260 (+0.1166%)
     
  • BTC-USD

    55,008.68
    +83.94 (+0.15%)
     
  • CMC Crypto 200

    1,281.72
    +18.76 (+1.49%)
     
  • FTSE 100

    6,909.82
    +14.53 (+0.21%)
     
  • Nikkei 225

    29,188.17
    +679.62 (+2.38%)
     

MaxLinear Starts $100M Share Buyback Program

  • Oops!
    Something went wrong.
    Please try again later.
Anusuya Lahiri
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • MaxLinear Inc (NYSE: MXLauthorized a 0 million share buyback program.

  • The program is slated to expire on February 16, 2024, and funded from available working capital. The company had cash and equivalents of $150.03 million as of December 31, 2020.

  • “We are excited about our future as we continue to drive growth in our data connectivity and access platforms, 5G wireless infrastructure, high-speed optical data center interconnects, and power and industrial interfaces,” said MaxLinear CEO Kishore Seendripu, Ph.D. “The stock repurchase program we are announcing today demonstrates our confidence in our long-term growth prospects and commitment to delivering stockholder value,” added Seendripu.

  • MXL stock has gained 122.8% in one year.

  • Price action: MXL shares were higher by 3.75% at $41.50 in the pre-market session on the last check Wednesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.